Metal Compounds in Cancer Therapy

The discovery of the anti-tumour activity of cisplatin in 1965, and its subsequent introduction into clinical trials in 1971, was the catalyst for a major research effort into the potential of metal compounds in cancer therapy. This book provides a discussion of metal compounds in cancer therapy. This book should be of interest to research workers in the pharmaceutical industry, particularly tumour pharmacologists, tumour biologists, medicinal chemists and oncologists.